AIMS To determine the clinical features of a large number of unselected UK hospital patients with confirmed septic arthritis and to determine those features associated with a poor outcome.
STUDY DESIGN Retrospective, case-note survey.
SETTING A single English Health District.
PATIENTS All patients admitted to hospital in Nottingham during the period 1 January 1982 to 31 December 1991 with confirmed septic arthritis were included.
OUTCOME MEASURES Death, osteomyelitis and recorded functional impairment.
RESULTS The spectrum of causative organisms remains similar to that seen in previous studies with the Gram positive organisms Staphylococcus aureus and Streptococci responsible for 74% of cases, gonococcal infections though were less common. Culture of joint aspirates and or blood were positive in 82% of cases, with the Gram stain demonstrating the causative organism in 50% of cases. Pre-existing joint disease was evident in 35% of cases. The mortality remains high at 11.5% with a significant additional morbidity of 31.6%. Multivariate analysis suggests that important predictors of death are: confusion at presentation, age ⩾65 years, multiple joint sepsis or involvement of the elbow joint, and of morbidity are: age ⩾ 65 years, diabetes mellitus, open surgical drainage, and Gram positive infections other than S aureus.
CONCLUSIONS Septic arthritis continues to be associated with a considerable degree of morbidity and mortality. These results confirm the importance of obtaining synovial fluid and blood for culture before starting antimicrobial treatment. The apparent poorer outcome found with surgical intervention is in line with some previous suggestions but should be interpreted with caution in light of the retrospective nature of this study.
Statistics from Altmetric.com
Septic arthritis remains an important infection, associated with both significant mortality and morbidity.1-7However, many studies of its clinical features have mainly been small or concentrated on selected patient populations (adults, children or surgical infections). Although secular trends in the nature of the disease, both in terms of the risk factors involved and the nature of the pathogens implicated, have been suggested, no recent large scale systematic studies of septic arthritis have been reported in the United Kingdom.1 2 Furthermore, systematic data on the causative pathogens in septic arthritis are not routinely collated by many microbiology departments or by the Communicable Disease Surveillance Centre (CDSC).7 This makes development of appropriate treatment and management protocols problematic.8
This study was undertaken to determine the spectrum of septic arthritis seen at two major teaching hospitals serving a single UK Health District (population 632 000) over a 10 year period. The study was designed to be as comprehensive as possible and used multiple methods of patient ascertainment.
The essential features of this definition are (table 1):
- 1 Microbial pathogen identified in, or isolated from synovial fluid or joint tissues
- 2 Typical features of septic arthritis with pathogen isolated from other source(s), for example, blood
- 3 Pus obtained from the joint but joint culture sterile because of previous administration of antibiotics
- 4 Definite radiological or postmortem diagnosis of septic arthritis
The major source of patient ascertainment was the Hospital Activity Index (HAI) for the two major Nottingham Hospitals, (City Hospital Trust and University Hospital Trust) for the period 1 January 1982 to 31 December 1991. Patients coded as having pyogenic arthritis, gonococcal arthritis, tuberculous arthritis and arthritis in association with salmonellas and streptococci were identified. To maximise the number of cases identified additional sources of ascertainment were also used. These included: the ward admission book of the rheumatology ward (1 January 1982 to 31 December 1991); the microbiology department computer records for all positive synovial fluid culture results (1 January 1991 to 31 December 1991); the orthopaedic theatre book (1 January 1991 to 31 December 1991); notifications of bone and joint infections with bacteraemia to the Communicable Disease Surveillance Centre (CDSC) (1 January 1988 to 31 December 1991); and the diagnostic index of two rheumatology consultants. Septic arthritis was defined by the criteria of Newman1 as modified by Cooper and Cawley2 and outlined above.
All patient notes were examined in a structured fashion using a standard proforma. Record was taken of: patient age and sex at presentation; delay in presentation; method of referral to hospital; specialty referred to; previous history of joint disease; history of recent trauma or instrumentation; underlying immunosuppression either because of drugs and/or disease; maximum fever during the first week of admission; white blood cell count and differential, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), serum urea and creatinine; dates of hospital stay; results of microbiological testing; details of medical and surgical treatment; and assessment of functional outcome as recorded in the notes. Delay in presentation was defined as the interval, in days, between the onset of symptoms attributable to septic arthritis and presentation of the patient to medical services. Delay in diagnosis is the interval from onset of symptoms to the specific diagnosis of septic arthritis being considered. Sepsis was considered to have contributed to death when no other specific cause, for example, terminal malignancy was apparent from the notes.
Appropriateness and adequacy of antibiotic dose and duration was determined from the limited published data on recommended drug doses for bone and joint infections9-11 and took into account the patient’s age and previously described risk factors (for example, immunosuppression, prosthetic material, rheumatoid disease). In the absence of a generally agreed consensus on antibiotic treatment duration a relaxed definition was used to define adequate dose duration. For intravenous antibiotics an adequate course was defined as an appropriate dose given for at least seven days in adults, three days in a child or until death. An adequate oral duration was similarly defined as an adequate dose given for at least 14 days or until death.
Multiple logistic regression analysis (SPSS) was used to determine risk factors for outcome. Mortality was used as a dependent variable versus all survivors. Recorded poor outcome and osteomyelitis were analysed compared with those patients with a recorded good outcome. Logistic regression was used (SPSS) with all potential risk factors entered into the model. These included: age (in the case of mortality age ⩾65; in the case of morbidity entered as the age groups ⩽4, 5–15, 16–64, ⩾65 years); confusion; open surgery; arthroscopic surgery; delay (⩽ 3days, >3 days); diabetes mellitus; joint involvement (hip, knee, shoulder, elbow, other, multiple); organism (no organism identified, Staphylococcus aureus, streptococci, other Gram positive organisms, Gram negative organisms (other than Haemophilus influenzae), Haemophilus influenzae; presence of prosthetic material; closed (percutaneous) needle drainage; sex; and concurrent oral corticosteroids. In the case of multiple organisms the patient was classified according to the predominant organism. In three patients the culture was S aureus and Group A streptococci and they were analysed as S aureus; two patients had mixed Gram negative organisms and the final patient had mixed Gram positive organisms and was included in the other Gram positive group.
Four hundred and seventy six possible cases of septic arthritis were identified of which 462 medical notes were traceable and examined. The majority of potential cases (371) were identified using the HAI. Comparison with other sources of information not all of which were available for the whole 10 year period produces an estimate suggesting that using the HAI would have missed 35% of all cases. From these 239 patients with 243 separate episodes of sepsis were identified as fulfilling the criteria for septic arthritis. The numbers fulfilling the various diagnostic criteria are tabulated (table 1). One patient was transferred to a private hospital and their final outcome is unknown and thus 242 patients were evaluable for the outcome analysis.
PATHOGENS AND JOINTS INVOLVED
Causative organisms were cultured in 199 cases (82%) these are listed (table 2). In common with previous studies S aureus was the commonest pathogen in all age groups but unlike earlier surveys H influenzae andNeisseria gonorrhoeae were uncommon. As expected 95% of S aureus isolates were penicillin resistant. The different organisms found in the different risk groups are tabulated (table 3). Gram negative infections were uncommon but more likely in patients with diabetes mellitus.S aureus was more common in those with prosthetic material and patients with rheumatoid arthritis.H influenzae was almost exclusively isolated in those less than 4 years old.
The joints involved are tabulated (table 4). The commonest joint involved was the knee joint but it should be noted that septic arthritis presented in multiple joints in 15% of cases.
The major potential risks factors for the development of septic arthritis are listed (table 5). Twenty two per cent of patients had no readily identifiable risk factor for septic arthritis. Previous joint disease was evident in only 35% of cases; 65% of patients had previously apparently normal joints. Rheumatoid arthritis was extremely commonly seen (16%) compared with its expected frequency in the population of approximately 1%. Septic arthritis was found to be more common at the extremes of age (fig 1). Using estimates derived from only those cases resident in the Nottingham Health Authority (161 cases) the overall crude incidence rate was 2.6/100 000 person years (95% confidence intervals 2.4, 2.8). Assuming this represents an under ascertainment of cases of 35% this suggests an overall incidence of 4 per 100 000 person years. The sex incidence was approximately equal (male 2.59, female 2.65). The age specific incidence rate is also shown (fig 1).
DIAGNOSIS AND PRESENTATION
The median delay in presentation was three days, (interquartile range of 1–7 days). Forty eight per cent of patients were referred via their general practitioners and 41% via casualty. The majority of patients were referred to the orthopaedic and rheumatology specialties but a variety of specialties need to be aware of the diagnosis and its management (table 6). Delay in diagnosis often occurred with a mean value 9.7 days.
One hundred and sixty two patients (67%) had a positive microbiological culture result from a joint aspirate; in 58 (24%) the blood cultures were also positive. In an additional 22 patients (9%), blood cultures were the only source of a positive microbiological diagnosis.
It is not possible to determine the sensitivity and specificity of the various microbiological tests in diagnosing septic arthritis because of the selective nature of this series. However, it is possible to determine the value of ancillary investigations. Fever was only present in 58% of cases and the total white cell count was increased in only 50% of the 208 cases were it had been tested (based on age specific reference ranges, normal adult range 4–11.5 × 109l-1). The ESR, performed in 138 patients was often only moderately increased and occasionally normal. In contrast the CRP (measured in 51 patients) was usually raised and greater than 100 mg/ml (normal < 20 mg/ml ). (fig 2).
Of 239 patients in whom data on initial antibiotic treatment were available an appropriate initial antibiotic was given in 207 (87%). A total of 21 different antibiotic combinations were, however, used in initial treatment with the commonest being flucloxacillin and an aminopenicillin (52 patients), flucloxacillin and fusidic acid (47), flucloxacillin and benzylpenicillin (27), and flucloxacillin alone (26).
Of 233 patients in whom details of intravenous therapy were available the dose used was inadequate in 59 (34%). With oral antibiotics 25 of 207 (12%) of patients received an inadequate dose. The duration of treatment was very variable with a mean length of intravenous therapy and oral therapy of 10.2 days and 55.3 days respectively. Of 173 patients receiving adequate intravenous dose in whom the duration of treatment was known, an inadequate duration was observed in 24 (14%). The figure for oral antibiotic duration was 13 of 179 (7%).
This series demonstrated that septic arthritis is associated with a significant mortality of 11.5%; all but one of the 29 deaths being directly attributable to sepsis. The morbidity is also considerable at 31.6% (osteomyelitis 7.8%; poor functional outcome in 23.8%) and the average hospital inpatient bed stay was 26.7 days. Univariate risk factors (table 7 and table 8) and multivariate risk factors (table 9and table 10) for death and morbidity are tabulated.
Univariate analysis suggests that confusion at presentation, percutaneous drainage, and age greater than 65 years were associated with increased mortality whereas open surgical drainage was associated with reduced mortality. Multivariate analysis suggested, however that confusion, age greater than 65 years and multiple or elbow joint involvement were independently associated with increased mortality whereas open drainage was associated with a reduced mortality.
With regard to morbidity, a delay in presentation of greater than three days, the presence of prosthetic material and both arthroscopic and open surgical drainage were associated with increased morbidity (poor function or osteomyelitis). Age less than 4 years was associated with a better outcome. On multivariate analysis, age greater than 65 years, diabetes mellitus, open surgical drainage and infection with Gram positive organisms other than S aureus were independently associated with poor outcome whereas closed (percutaneous) drainage, age less than 4 years and infection withH influenzae were associated with a better outcome.
As the number of patients in whom antibiotic data are available is variable the effect of antibiotic threatment on outcome has been analysed separately. The mortality was the same in those given inappropriate or appropriate initial treatment; 9% and 12% respectively (p>0.05, Fisher’s exact test). Similar results were observed for inappropriate and appropriate: dose of intravenous antibiotic, 10% and 10% (p>0.05); dose of oral antibiotic, 4% and 1% (p>0.05)); duration of intravenous antibiotic, 4% and 11% (p>0.05); or duration of oral antibiotic, 8% and 1% (p>0.05). For poor outcome the figures are for inappropriate and appropriate: initial treatment, 38% and 36% (p>0.05); dose of intravenous antibiotic, 34% and 37% (p>0.05); duration of intravenous antibiotic, 52% and 34% (p>0.05); dose of oral antibiotic, 38% and 35% (p>0.05); and duration of oral dose, 33% and 35% (p>0.05). Thus no discernible effect of the choice or duration of antibiotic on outcome was apparent.
Septic arthritis is an important rheumatological and orthopaedic emergency. Despite this data regarding its clinical features are surprisingly scant. The main virtue of this study is the ascertainment of patients referred to a typical UK health district over a 10 year period regardless of any specific exclusion criteria. In this respect it is similar to previous studies UK studies1 2 although these did exclude some organisms and risk groups. It is also similar to the recent study by Kavanagh and colleagues.7 This latter study is, however, biased by its method of case ascertainment as it relied on the spontaneous reporting of septic arthritis through the PHLS Communicable Disease Reporting system. This may have resulted in over-representation of unusual organisms and those associated with bacteraemia. In common with these studies its major drawback is its retrospective nature.
The reliance on the HAI data to identify cases is a problem. Alternative means of ascertainment has allowed some estimate of the number of cases missed (35%) but this is only possible for some of the period under study. There is no a priori reason to suppose that this would have biased the results although we cannot exclude this possibility. Failure to obtain case-records is not a major problem with this study as we obtained over 95% of all case records. Finally the use of specific rather than sensitive criteria for septic arthritis means that patients may have been misclassified. This is particularly true of those patients who did not undergo joint aspiration as well as those patients who had pus aspirated while taking antibiotics but who in reality were probably suffering from an inflammatory or crystal related arthropathy. The number of such patients is unclear and their exclusion probably does not significantly change the conclusions obtained.
Prospective studies have now been reported from Amsterdam both using a reporting system in the community3 and for a cohort of patients with rheumatic disorders.12 These give broadly similar results for the spectrum of organisms seen. The incidence of septic arthritis in this study was 5.7 cases per 100 000 inhabitants per year with again a very increased incidence in rheumatoid arthritis.
This study suggests that the main features of septic arthritis are as previously demonstrated.1-5 In particular the age groups and joints affected as well as the risk factors are confirmed. However, there has been a change in the nature of the pathogens involved over the past 20 years with penicillin sensitive S aureus now a rarity. It should, however, be noted that in keeping with previous studies and teaching 74% of cases were attributable to S aureus and Streptococci.H influenzae type b was an important pathogen in children as demonstrated in this series but with the recent successful introduction of the specific vaccine a marked decline in its incidence in invasive disease has already been demonstrated.13 The incidence of gonococcal arthritis is much lower than in a previous UK survey2 and in accord with a recent study also from Europe.3 This continues to be in contrast with reports from urban areas of North America14 and tropical Australia4 and the reason for this difference remains unclear, but may be because of different circulating serotypes.15
These data strongly support the need to obtain synovial fluid before the commencement of antibiotic treatment and also emphasise the importance of an immediate Gram stain of the fluid obtained. However, it is also clear that blood cultures also contribute to the diagnosis and should not be omitted. Over-reliance on other features such as the white cell count, temperature, and ESR may be misplaced. The measurement of CRP may be a more sensitive indicator of possible septic arthritis. This study also re-emphasises that multiple joints are not uncommonly affected2-5 and that sepsis must still be considered in a patient presenting with multiple hot joints.
The association between delay in diagnosis and increased morbidity has been noted before.1 2 It emphasises the need to maintain a high index of suspicion for the condition, particularly in at risk groups. Early referral and assessment is to be emphasised.
This study also suggests that antibiotic treatment was not always used appropriately. It is difficult to draw firm conclusions from retrospective treatment but the wide variation in doses, variations and agents used would seem difficult to rationalise. Even when antibiotics were given it is difficult to understand why, what might be considered by many to be inadequate doses were used for such a potentially serious condition. It is surprising, however, that an inappropriate use of antibiotic was not associated with a poorer outcome although this may reflect the small numbers of patients involved, their heterogeneous nature and the predominance of other risk factors for poor outcome.
This study emphasises the continuing role of Gram positive infections in septic arthritis, it is therefore important that antibiotic treatment regimens are effective against Gram positive organisms and therefore should be based on a b-lactamase stable penicillin such as flucloxacillin. The addition of an agent with Gram negative activity such as second or third generation cephalosporin should be considered in the elderly, immunocompromised, or in young children, particularly those who have not had the Hib vaccine. Treatment should be modified in light of the Gram stain and culture results.
The suspicion that surgical intervention may be associated with poor outcome is not new.16 Again a major difficulty with interpreting this, results from the retrospective nature of these data. It is of course conceivable that early surgical intervention was used for the worst cases, those with a presumed poorer prognosis. However, even in apparently young fit adults with no other adverse risk factors (immunosuppression, trauma, pre-existing arthritis) this increase in poor outcome was still observed with open surgery. It may be that arthroscopy is not associated with poor outcome although the selection of patients for and timing of such intervention is still unclear. Although it is difficult to perform a randomised controlled trial in what remains a relatively rare disease that presents to many specialties and that involves surgical intervention in one arm, the need for further evidence for the benefit of various surgical interventions remains.17
We are extremely grateful to all the medical staff in Nottingham for allowing us to review the notes of patients under their care. We are also grateful to Mrs B Eggington, and all the staff of the audit offices at CHN and QMC for their invaluable help in identifying and obtaining patient notes, and to Mr D Woodcock, information analyst at District Headquarters for providing demographic details of the Nottingham Health Authority.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.